Business

Specializes in developing and manufacturing genetically engineered drugs; somatropin, interferon, including monoclonal affinity columns for recombinant subtypes, kits for fertility and sperm detection, in Hefei, China.

Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product pipeline and profile of company in Woburn, Massachusetts.

Established manufacturer of drug for treatment of multiple sclerosis, with research focusing on respiratory diseases and congestive heart failure. Offices throughout Europe, Canada with headquarters in Cambridge, Massachusetts.

Researches and develops therapies for debilitating, fatal, chronic genetic disorders causing enzyme deficiency of carbohydrate metabolism, such as phenylketonuria. Headquarters in Novato, California. (Nasdaq: BMRN).

Company engaged in the development of nutraceuticals, novel anti-infectives, such as the enzymatic modification of existing antibiotics. Domiciled in Zurich, Switzerland

A global healthcare company. Plasma-derived medicines, biopharmaceuticals and transfusion medicine.

Company developing small-molecule drugs and recombinant DNA proteins, which regulate gene activity and genetic processes in cancer and other diseases. Includes product information for patients and professionals from San Diego, California. (Nasdaq: LGND)

Discovers and develops drugs targeting skeletal, endocrinological, gastrointestinal, and central nervous system. Includes glossary, stages in pipeline, careers in North America, and investment in Salt Lake City, Utah. (Nasdaq: NPSP).

Offers novel platforms for the production of protein therapeutics, as well as technology and processes for the purification and formulation. Includes preclinical status of products, and details of corporation in Leiden, The Netherlands.

Develops and commercializes innovative products for the treatment of melanoma, prostate cancer, viral diseases, including HIV. Information for investors, and details of the company in Tarrytown, New York. (Nasdaq: PGNX)

Researches, develops, manufactures and markets synthetic version of protein A for monoclonal antibody processing, and peptides such as secretin for gastrointestinal and pediatric neurology. Details for investors and clinical programs run from Waltham Massachusetts. (Nasdaq: RGEN)

Products targeted on rare inherited disorders, kidney disease, orthopaedics, transplant and immune disease, cancer, and diagnostic testing. Includes links to global subsidiaries, headquartered from Cambridge, Massachusetts.

Develops and markets products targeted for treatment of cancer and diseases such as hepatitis B and C, cystic fibrosis and immune system disorders. Based in San Mateo, California. (Nasdaq: SCLN)

Corporate information on treatments for ophthalmia, hepatitis, dermatitis, angiopathy and illnesses associated with aging, from Beijing, China.